Cook, G <br/><br/>
Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy.  [electronic resource] 

 -  Leukemia  Dec 1997 
 - S35-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--therapeutic use<br/>Colony-Forming Units Assay<br/>Cyclophosphamide--therapeutic use<br/>Cytarabine--therapeutic use<br/>Dexamethasone--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Etoposide--therapeutic use<br/>Female<br/>Flow Cytometry<br/>Hematopoietic Stem Cell Mobilization--methods<br/>Humans<br/>Idarubicin--administration & dosage<br/>Male<br/>Mesna--therapeutic use<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Remission Induction